Skip to main content
Novo NordiskPartnership

Podiatrist let unlicensed salesman perform surgery, then billed Medicare; Novo Nordisk partners with OpenAI to accelerate drug development; a better predictor of hypertension...

Source: Autobound Signal API · 93 signals tracked for Novo Nordisk · updated

Get Novo Nordisk's live signals in Claude or ChatGPT, or by API

AskWhat changed at Novo Nordisk this week? Use Autobound signals for novonordisk.com.

What happened

Novo Nordisk has partnered with OpenAI to deploy artificial intelligence across its research, manufacturing, supply chain, and commercial operations.

Source

Article excerpt

California podiatrist let unlicensed salesman perform surgery, then billed Medicare Both men were sentenced to 63 months in prison for a $3.2 million health care fraud consipiracy. A California podiatrist and a pharmaceutical sales representative have each been sentenced to more than five years in prison for allowing the unlicensed salesman to perform surgical procedures - including using a scalpel to debride wounds on patients with recent foot amputations - while billing Medicare, Medicaid and Medi-Cal as if licensed physicians had done the work. Felipe Ruiz, D.P.M., 52, who owned West Coast Podiatry (WCP) in California's Central Valley, purchased skin grafts from Jose Aguirre, 53, and permitted him to apply them and perform other procedures on patients unsupervised between 2021 and 2024. Some patients believed Aguirre was a physician, calling him "Dr. Gabe." In one instance, WCP submitted $150,000 in Medicare claims for procedures performed while the physician of record was out of the country on vacation. Staff and third-party auditors raised concerns that were repeatedly ignored. In addition to their prison terms, Ruiz faces a $12.1 million forfeiture judgment and Aguirre a $2.6 million judgment, with nine properties also ordered forfeited. Novo Nordisk partners with OpenAI to accelerate drug development The deal covers research, manufacturing and commercial operations...

Keep reading with a free account

The rest of this article, and every signal for Novo Nordisk, is in your free account.

Extracted from this sentence

Novo Nordisk, the Danish drugmaker behind Ozempic and Wegovy, has announced a partnership with OpenAI, the artificial intelligence (AI) company behind ChatGPT, to deploy AI across its business, from drug discovery and manufacturing to supply chain and commercial operations, as they work to close the gap with Eli Lilly in the obesity drug market.

Extracted by Autobound

From the Signal API record
Event
Partnership

What this signalsA new partnership often opens integration and co-selling work.

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Oct 11, 2026
signal_type
news
signal_subtype
partners_with

Use this data

Get every partnership signal for Novo Nordisk and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novo Nordisk this week?”

  2. Send it to your own tools

    The Signal API returns partnership signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b428b501-e343-893e-80af-73cfaac9340a returns this record as JSON. POST /v1/companies/enrich returns every signal for novonordisk.com.

{
  "signal_id": "b428b501-e343-893e-80af-73cfaac9340a",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-10-11T04:14:18+00:00",
  "company": {
    "name": "Novo Nordisk",
    "domain": "novonordisk.com"
  },
  "data": {
    "url": "https://www.medicaleconomics.com/view/podiatrist-let-unlicensed-salesman-perform-surgery-then-billed-medicare-novo-nordisk-partners-with-openai-to-accelerate-drug-development-a-better-predictor-of-hypertension-risk-morning-medical-update",
    "title": "Podiatrist let unlicensed salesman perform surgery, then billed Medicare; Novo Nordisk partners with OpenAI to accelerate drug development; a better predictor of hypertension risk – Morning Medical Update - Medical Economics",
    "excerpt": "California podiatrist let unlicensed salesman perform surgery, then billed Medicare Both men were sentenced to 63 months in prison for a $3.2 million health care fraud consipiracy. A California podiatrist and a pharmaceutical sales representative have each been sentenced to more than five years in prison for allowing the unlicensed salesman to perform surgical procedures - including using a scalpel to debride wounds on patients with recent foot amputations - while billing Medicare, Medicaid and Medi-Cal as if licensed physicians had done the work. Felipe Ruiz, D.P.M., 52, who owned West Coast Podiatry (WCP) in California's Central Valley, purchased skin grafts from Jose Aguirre, 53, and permitted him to apply them and perform other procedures on patients unsupervised between 2021 and 2024. Some patients believed Aguirre was a physician, calling him \"Dr. Gabe.\" In one instance, WCP submitted $150,000 in Medicare claims for procedures performed while the physician of record was out of the country on vacation. Staff and third-party auditors raised concerns that were repeatedly ignored. In addition to their prison terms, Ruiz faces a $12.1 million forfeiture judgment and Aguirre a $2.6 million judgment, with nine properties also ordered forfeited. Novo Nordisk partners with OpenAI to accelerate drug development The deal covers research, manufacturing and commercial operations...",
    "summary": "Novo Nordisk has partnered with OpenAI to deploy artificial intelligence across its research, manufacturing, supply chain, and commercial operations.",
    "planning": true,
    "image_url": "https://cdn.sanity.io/images/0vv8moc6/medec/0ac785192e2764d5b7f7f6edd9a059ea6cb66ce8-1200x783.jpg",
    "confidence": 0.95,
    "published_at": "2026-10-11T04:14:18Z",
    "article_sentence": "Novo Nordisk, the Danish drugmaker behind Ozempic and Wegovy, has announced a partnership with OpenAI, the artificial intelligence (AI) company behind ChatGPT, to deploy AI across its business, from drug discovery and manufacturing to supply chain and commercial operations, as they work to close the gap with Eli Lilly in the obesity drug market.",
    "related_company_name": "OpenAI",
    "related_company_domain": "openai.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.